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In Brief
DNA methylation influences multiple
biological processes but has typically not
been considered in genome-wide
association studies. Studying 90 mouse
inbred strains, Orozco et al. show that
DNAmethylation is highly variable among
individuals and associated with
molecular and clinical traits that are
precursors to heart disease, diabetes,
and osteoporosis.
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Heritable epigenetic factors can contribute to com-
plex disease etiology. Here we examine the contribu-
tion of DNA methylation to complex traits that are
precursors to heart disease, diabetes, and osteopo-
rosis. We profiled DNA methylation in the liver using
bisulfite sequencing in 90 mouse inbred strains,
genome-wide expression levels, proteomics, metab-
olomics, and 68 clinical traits and performed epige-
nome-wide association studies (EWAS). We found
associations with numerous clinical traits including
bone density, insulin resistance, expression, and
protein and metabolite levels. A large proportion of
associations were unique to EWAS and were not
identified using GWAS.Methylation levels were regu-
lated by genetics largely in cis, but we also found
evidence of trans regulation, and we demonstrate
that genetic variation in the methionine synthase
reductase geneMtrr affects methylation of hundreds
of CpGs throughout the genome. Our results indicate
that natural variation in methylation levels contrib-
utes to the etiology of complex clinical traits.
INTRODUCTION
Methylation of DNA cytosine bases is evolutionarily conserved in
multiple species from plants to humans. In mammalian species,
DNAmethylation plays an important role in imprinting, X chromo-
some inactivation, cell differentiation, gene silencing, and regu-
lation of gene expression. Similar to genetic variation, epigenetic
modifications are variable between individuals and regulated by
genetics (Orozco et al., 2014). Methylation QTL (metQTL) studies
in human adipose tissue found that 28% of CpGs were associ-
ated with nearby SNPs (Grundberg et al., 2013). DNA methyl-Cation is variable between inbred strains in Arabidopsis, rice,
and mice and in human populations. Strain-specific methylation
patterns were maintained across generations in mouse strains,
and twin studies in humans have shown a higher concordance
of methylation patterns inmonozygotic twins relative to dizygotic
twins (Gordon et al., 2012; McRae et al., 2014), suggesting that
DNA methylation is under genetic control.
Both human populations and mouse strains show variation in
multifactorial traits like heart disease and osteoporosis. In the
past decade, genome-wide association studies (GWAS) have
identified hundreds of genetic variants influencing clinical traits
(Welter et al., 2014). DNA methylation has also been associated
with gene expression (Bell et al., 2011; Grundberg et al., 2013)
and complex traits including cancer (Shenker et al., 2013; Xu
et al., 2013), aging (Heyn et al., 2013; Horvath, 2013), multiple
sclerosis (Huynh et al., 2014), rheumatoid arthritis (Liu et al.,
2013), and obesity in humans (Dick et al., 2014). However,
althoughDNAmethylation is influencedbygeneticsandcouldac-
count for part of the heritability of clinical traits, epigenetic varia-
tionhas typically notbeenconsidered inGWASfor complex traits.
In this study, we performed epigenome-wide association
studies (EWAS) to determine the contribution of DNA methyl-
ation to complex clinical traits related to heart disease, diabetes,
obesity, and osteoporosis. Our study integrates systems ge-
netics data that includes SNP genotypes, DNA methylation
bisulfite sequencing data, genome-wide gene expression, prote-
omics, metabolomics, and clinical phenotypes. Our results
reveal a large number of associations between DNA methylation
variants and clinical or molecular traits, many of which we could
not identify using traditional GWAS. We explored the contribu-
tion of genetics to DNA methylation patterns and found that
52% of highly variable CpGs were under genetic control. The
narrow sense heritability for CpG methylation levels was on
average 27% and was 60% for highly variable CpGs. We also
present evidence of common genetic variation affecting DNA
methylation patterns in trans and experimentally validate the
role of Mtrr in regulating methylation levels of CpGs across the
genome.ell Metabolism 21, 905–917, June 2, 2015 ª2015 Elsevier Inc. 905
RESULTS
Data
We constructed reduced representation bisulfite sequencing
(RRBS) libraries using liver genomic DNA from 16-week-old
male mice using a previously described protocol (Smith et al.,
2009), corresponding to 90mouse inbred strains from the Hybrid
Mouse Diversity Panel (HMDP) (Bennett et al., 2010). We
sequenced the libraries using the Illumina HiSeq platform and
obtained an average of 90 ± 11 million reads per sample, then
aligned the data to the mouse genome using BS-Seeker2 (Guo
et al., 2013) for an average of 41 ± 7 million uniquely aligned
reads per sample (Figure S1A). This corresponded to 46%
mappability and 483 coverage per sample on average (Fig-
ure S1B). We filtered the cytosines based on 103 or more
coverage for a total of 11,520,175 cytosines present in at least
90% of the samples, of which 2,047,165 were CG, 2,737,475
were CHG, and 6,735,535 were in CHH context. The mouse
genome contains 21.3 million CpGs, and we observed approxi-
mately 2 million (9.6%) of all CpGs using RRBS.
Global methylation levels in the adult mouse livers were 44%±
1% for CpG cytosines, 1.1% ± 0.4% for CHG, and 0.8% ± 0.4%
for CHH cytosines, where H is any base other than G (Fig-
ure S1C). Since non-CG methylation was too low to be studied
in these samples (Figures S1C and S1E), we focused our ana-
lyses on CG cytosines only. We defined a set of 360,324 Variable
CpGs, which showed a 50% absolute change (delta) in methyl-
ation levels in at least one sample. We further identified a set
of 22,227 Hypervariable CpGs, which showed 50% or higher
methylation delta, relative to the median methylation level of
the CpG in 5 or more samples. An example of a Variable and a
Hypervariable CpG can be found in Figures S2A and S2B. We
excluded 6,993 CpGs that were also SNPs in the mouse strains,
since the changes in methylation observed correspond to the
loss of a CpG in strains carrying the SNP.
The liver is one of the main tissues involved in energy meta-
bolism. Because of its roles in carbohydrate and fat metabolism,
the liver has a significant impact on clinical phenotypes such as
plasma glucose, cholesterol and lipid levels, body weight,
adiposity, and atherosclerosis. It would also be important to
consider methylation levels in other metabolically relevant tis-
sues such as adipose, muscle, pancreas, and intestine in future
studies. For the same mouse strains, we measured 68 clinical
traits including atherosclerosis, diabetes, obesity, osteoporosis,
and blood-cell-related traits, aswell as genome-wide expression
levels in the liver (Bennett et al., 2010) using Affymetrix arrays.
We obtained liver proteomics from 1,543 peptides measured
by liquid chromatography-mass spectrometry (Ghazalpour
et al., 2011). We also profiled 260 liver and plasma metabolites
usingmass spectrometry, comprising eight classes ofmolecules
including lipids, carbohydrates, amino acids, peptides, xenobi-
otics, vitamins, cofactors, and nucleotides (Ghazalpour et al.,
2014).
DNA Methylation Has Lower Correlation in Cis
than SNPs
Correlations between pairs of alleles that are near each other on
a chromosome, or linkage disequilibrium (LD), can result in large
genomic blocks that contain multiple genes. A given association906 Cell Metabolism 21, 905–917, June 2, 2015 ª2015 Elsevier Inc.may have a few or dozens of candidate genes depending on the
level of LD at that locus. We were interested in determining the
correlation in pairwise CpG methylation levels, and hence
the level of resolution we could achieve using CpGs in our asso-
ciation studies. We determined pairwise correlations of CpGs at
different distances from each other. For example, we took CpGs
separated by 100 kb or less and estimated the correlation be-
tween the CpG methylation levels in the HMDP strains. We
then estimated the average correlation between all pairs of
CpGs in the genome at that distance from each other and
repeated this estimate at various distances. We compared this
to the level of correlation in SNPs (LD) that we had previously
calculated for the same HMDP strains (Bennett et al., 2010).
Pairwise correlations in CpG methylation levels for a locus on
chromosome 1 are shown in Figure 1A for VariableCpGs,Hyper-
variable CpGs (Figure 1B), and SNPs (Figure 1C). Methylation
levels in mouse strains for a sample locus in chromosome 1
are shown in Figure 1D, where methylation levels vary between
0% and 100%. Correlations plots for whole chromosomes can
be found on Figures S3D–S3I.
At the genome-wide level, we found that the distance-depen-
dent correlation betweenCpGswas lower than that of SNPs. The
average correlation across the genome between CpGs within
100 kb was r2 = 0.06 for Variable CpGs and r2 = 0.43 for Hyper-
variableCpGs, and at 2Mb, the average correlation was r2 = 0.03
for Variable CpGs and r2 = 0.17 for Hypervariable CpGs. In
contrast, the average correlation across the genome was r2 =
0.88 for SNPs at 100 kb, dropping to r2 = 0.49 at 2 Mb. The
genome-wide average of pairwise correlations is shown on Fig-
ure 1E, for CpGs or SNPs at various distances from each other in
increasing 100 kb bins. Since methylation levels in mammals are
bimodal for a large proportion of CpGs (Figure S1D), we exam-
ined pairwise correlations between CpGs with low or high
methylation levels. We found that Hypervariable CpGs with low
methylation levels were generally more highly correlated with
nearby CpGs than CpGs with high methylation levels. For
example, the average correlation between Hypervariable CpGs
at 100 kb was r2 = 0.68 for CpGs with 0%–20% methylation
levels, and r2 = 0.58 for CpGs with 80%–100% methylation.
The average correlation was r2 = 0.32 for CpGs with 0%–20%
methylation levels, and r2 = 0.18 for CpGs with 80%–100%
methylation, at a distance of 2 Mb. We observed no differences
in pairwise correlation levels between low and high methylated
Variable CpGs (Figure 1F).
Natural Variation in DNA Methylation Is Associated with
Complex Traits
To determine the association of epigenetic variation with com-
plex clinical and molecular traits, we performed EWAS between
CpGmethylation levels and (1) 68 clinical traits, including plasma
cholesterol, fatty acids, glucose and insulin, body weight,
adiposity, blood cell counts, and bone mineral density pheno-
types; (2) 260 plasma and liver metabolites; (3) protein levels
from 1,543 peptides corresponding to 480 genes; and (4)
genome-wide microarray expression levels corresponding to
12,980 genes (Figure 2). Similar to GWAS using SNPs, we
used a linear mixed model (Kang et al., 2008) to determine asso-
ciations between traits and CpGs and to correct for population
structure. Since we used CpG methylation as the predictors
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Figure 1. Methylation and SNP Correlations
(A–C) Correlations for a locus in chromosome 1 in (A) Variable CpG methylation, (B) Hypervariable CpG methylation, and (C) SNPs. The x and y axes denote the
chromosome position, and the color represents the correlation (r2) between CpGs, or SNPs.
(D) Methylation levels of Hypervariable CpGs for a representative locus, strains are on the x axes, CpGs are on the y axes, and the color represents percent
methylation levels.
(E and F) Genome-wide average correlation between CpGs, or SNPs, at various distances. SNPs are shown in black; Variable CpGs are in blue; Hypervariable
CpGs are in red. Each point is the average correlation at increasing 100 kb bins.
(E) Genome-wide average correlation between CpGs binned by their methylation level. Open circles (o) represent the average for all CpGs; asterisks (*) represent
the average for CpGs with methylation levels between 0% and 20%, and plus symbols (+) represent the average for CpGs with methylation levels between 80%
and 100%. See also Figure S3.instead of SNPs, we also employed a methylation-based kinship
matrix instead of a SNP kinship matrix in the model. We and
others have shown that this approach corrects for false-positive
associations due to population structure (Bennett et al., 2010)
and potential tissue heterogeneity in the methylation data (Zou
et al., 2014).
Each of the EWAS plots in Figure 2 summarizes associations
between CpGs across the mouse genome and traits. Due to
the large number of traits in the proteomics and gene expression
data sets, only associations to Hypervariable CpGs are shown
for these data sets. All associations shown are significant at
the Bonferroni threshold (Table S1). In summary, we found that
natural variation in CpG methylation was associated with
numerous complex clinical and molecular traits. A table with
the number of EWAS hits and the significance threshold used
can be found Table S1, and tables with the individual associa-
tions we identified for all clinical and molecular traits can beCdownloaded from http://ewas.mcdb.ucla.edu/download.html.
We found no evidence of inflation in our EWAS results (Figures
S4A–S4D; Supplemental Information) and no evidence ofmacro-
phage contamination in our liver samples (Figures S4E and S4F).
EWAS Identifies Both Known and Novel Associations
We identified numerous associations between clinical traits and
CpG methylation near genes known to influence those traits,
including associations not identified using traditional GWAS.
We previously performed GWAS for clinical traits and expression
levels in the HMDP (Bennett et al., 2010). We also previously
examined LD for SNPs in the HMDP and estimated an average
resolution of 2 Mb (Bennett et al., 2010; Ghazalpour et al.,
2011; Orozco et al., 2012), although LD blocks could be smaller
or larger depending on the genomic region. We took the average
2 Mb resolution in the HMDP and called associations in 2 Mb
bins, such that more than one association in a bin wasell Metabolism 21, 905–917, June 2, 2015 ª2015 Elsevier Inc. 907
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Figure 2. EWAS
(A–D) Association between CpG methylation and (A) clinical traits, (B)
metabolites, (C) protein, and (D) gene expression levels. Each point is a sig-
nificant EWAS at the corresponding Bonferroni thresholds across all CpGs and
traits tested. The genomic position of CpGs is on the x axis, the y axis denote
traits, and the position in the genome of the associated proteins and
genes. Black points are EWAS hits forHypervariableCpGs, and blue points are
EWAS hits for VariableCpGs. For simplicity, only associations toHypervariable
CpGs are shown for the proteomics and gene expression data sets. See also
Figure S4.
908 Cell Metabolism 21, 905–917, June 2, 2015 ª2015 Elsevier Inc.considered to be the same locus. To look for the overlap be-
tween GWAS and EWAS associations, we considered associa-
tions to be overlapping if they were within 2 Mb of each other.
For clinical traits common to both studies, we identified 266
EWAS hits and 300 GWAS hits, and 41 were identified by both
EWAS and GWAS where the associated loci were within 2 Mb
of each other. We also observed that the overlap between
EWAS and GWAS hits was much higher for expression cis-
eQTL (77%) and protein (37%) cis-pQTL (Figure S5A). Clinical
traits are typically more complex than molecular traits such as
gene expression or protein levels. For increasingly complex
traits, a smaller proportion of the variance in the phenotype
can be explained by genetic or epigenetic variation. Therefore,
for a given statistical power, we are likely to detect far more
molecular QTL than clinical trait QTL. The low overlap between
EWAS and GWAS clinical trait hits may be due to a lack of
sufficient power to detect associations for complex traits, since
we also observe a higher overlap between EWAS and GWAS
associations for expression cis-eQTL (77%) than for clinical
traits (15%).
As an example, we found an EWAS hit on chromosome 13 for
adipose tissue insulin resistance (ATIRI), glucose-to-insulin ratio,
a measure of insulin sensitivity, and percent of monocytes in the
blood (Figures 3A–3C). We did not find an association using
GWAS for measures of insulin resistance or monocyte levels at
this locus. The gene Bhmt encoding betaine-homocysteine
methyltransferase located at 94.3 Mb on chromosome 13 was
a candidate gene in this locus, since we also identified a cis as-
sociation for protein levels of this gene using EWAS, or cis-pQTL,
but no expression associations (Figures 3D and 3E). Methylation
levels at this locus were correlated with glucose-to-insulin ratio
(Figure 3F) and inversely correlated with protein levels of the
gene (Figure 3G). Protein levels of Bhmt were also correlated
with the trait (Figure 3H). Previous work in Bhmt knockout mice
demonstrated that Bhmt plays a role in energy metabolism, spe-
cifically in lipid synthesis, and insulin sensitivity (Teng et al.,
2012). Additional examples for associations with plasma choles-
terol and total bone mineral density are describe in the Supple-
mental Information and Figure S6.
Conditional Association Studies
We used conditional association studies to determine whether
hits identified with both EWAS and GWAS were (1) caused by
the same signal or (2) co-localizing but independent signals. To
accomplish this, we performed EWAS for overlapping associa-
tions using the CpG as the predictor and the SNP genotype as
a covariate. In this approach, if an EWAS hit remains significant
when we use the SNP as a covariate, this would suggest that the
overlapping EWAS and GWAS association was independent but
co-localizing. In contrast, if the EWAS hit goes away when we
use the SNP as a covariate, then we can conclude that the
EWAS and GWAS overlapping association was arising from
the same signal. Out of 41 overlapping clinical trait associations,
only three (7%) remained significant when we used the SNP ge-
notype as a covariate at the Bonferroni threshold (p < 1.2 3
103), and none were significant at p < 1 3 107. Similarly, 71
(4%) of overlapping cis expression associations, corresponding
to 64 unique genes, remained significant after using the SNP ge-
notype for the locus as a covariate at the Bonferroni threshold
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Figure 3. Insulin Resistance and Bhmt
EWAS
(A–E) Manhattan plots showing association of
methylation levels to (A) ATIRI, (B) plasma glucose-
to-insulin ratio, (C) monocyte percent in the blood,
(D) liver protein levels of Bhmt, and (E) liver
expression levels of Bhmt. Chromosome location
is on the x axis, the p value for the association is on
the y axis, and each point represents a CpG. The
dotted line is drawn at p < 13 107, the Bonferroni
threshold for a single phenotype.
(F–H) Each point represents a mouse sample,
showing correlation between (F) methylation levels
for the peak associated CpG and glucose-to-in-
sulin ratio levels, (G) methylation levels for the peak
associated CpG and liver protein levels of Bhmt,
and (H) glucose-to-insulin ratio and Bhmt protein
levels. See also Figure S6.(2.7 3 105), and 30 of the associations (2%) were significant at
p < 1 3 107. These results suggest that the majority of associ-
ations we found using both EWAS and GWAS were likely arising
from the same signal at the associated locus.
Causal Inference Test
To determine whether associations identified by both EWAS and
GWAS were mediated by differential methylation levels, we per-
formed causal inference tests (CITs) using the R statistical pack-
age CIT (Millstein et al., 2009). The CIT performs a series of con-
ditional probability tests todetermine if the associationbetweena
genetic locus (L) and a trait (T) is mediated by DNA methylation
(M), in this case, by testing for the following conditions: (1) the trait
is associated with the locus, L/T; (2) the trait is associated with
themethylationmediator given the locusM/T j L; (3) themethyl-
ation mediator is associated with locus given the trait, L/M j T;
and (4) the locus is independently associated with both themedi-
ator and the trait given the mediator, L/T j M. If the first three
conditions are met, we can say that genetic variation at the locusCell Metabolism 21, 905–is associated with the trait and that this
association is mediated entirely by DNA
methylation, L/M/T. Alternatively, if
all four conditions are met, we can say
that the association is still causal and
mediated by DNA methylation, but the
genotype at the locus also affects methyl-
ation and the trait independently. In sum-
mary, the two causal models tested by
the CIT are the causal model, where the
association is mediated entirely by DNA
methylation, and the causal independent
model, where the association is causal
but the locus is also independently associ-
ated with DNA methylation and the trait.
We performed the CIT for clinical trait
associations identified by both EWAS
and GWAS and found that ten out of the
41 (24%) overlapping associations were
causal andmediated byDNAmethylation,
and nine of the ten were causal indepen-dent associations (Table S2). However, it is possible that there
are additional causal relationships between genetic variants,
DNA methylation, and traits, but we lack sufficient power to
detect these. Similarly, we performed the CIT for the gene
expression associations (eQTL) we identified using both EWAS
and GWAS, corresponding to 1,530 unique genes. We found
352 (22%) cis-eQTL mapping genes were mediated by variation
inDNAmethylation,where the locusgenotype influencedmethyl-
ation and DNAmethylation in turn influenced the trait, L/M/T,
and 321 of these were causal independent. Overall, results from
the CIT indicate that a proportion (22%–24%) of overlapping
EWAS and GWAS hits were causal associations mediated by
DNA methylation. These results in conjunction with the condi-
tional association studies suggest that that remaining EWAS
hits are likely to be secondary to the genetic associations.
Principal-Component Analysis
The clinical traits in our study have a complex correlation structure
(Figure S5B), since several traits such as insulin resistance,917, June 2, 2015 ª2015 Elsevier Inc. 909
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Figure 4. Principal Component EWAS
(A and B) Association between methylation and
principal components (A) one and (B) two. Each dot
represents a CpG, the genomic position of CpGs is
on the x axis, and the log10 of the p value for the
association is on the y axis; chromosomes are
shown in alternating colors.
(C–F) Each dot represents amouse sample, showing
correlation between (C) liver expression levels of
Prelid1 and methylation levels of a CpG associated
with PCA1, (D) expression of Cmtm6 and methyl-
ation of a CpG associated with PCA1, (E) expression
of Lipe and methylation of a CpG associated with
PCA2, and (F) expression ofMtor and methylation of
a CpG associated with PCA2. See also Figure S5.plasmacholesterol levels, andobesity are interrelated. Toaccount
for correlationsbetweenclinical traits, and to identify loci thatdrive
multiple correlated traits, we performed principal-component
analysis on the clinical traits (Figure S5C). The first component ex-
plained 24% of the variation in the traits and had the highest
weights for glucose-to-insulin ratio and fat-related traits. The sec-
ond component explained 12% of the variation in the traits and
had the highest weights for blood- and fat-related traits. We per-
formed EWAS between CpGs and the two first principal compo-
nents as phenotypes and found two significant associations with
the first component on chromosomes 1 and 9 at the Bonferroni
threshold (p < 6.93 108, Figure 4A). We searched for individual
methylation sites in this locus that were also associated with
gene expression or protein levels. Genes associated with the
chromosome 1 locus methylation levels include Prelid1 (Fig-
ure 4C), a gene involved in lipid transport, and 1110057K04Rik,
a gene recently found to be involved in lipid storage (Goo et al.,910 Cell Metabolism 21, 905–917, June 2, 2015 ª2015 Elsevier Inc.2014). Methylation levels at the chromo-
some 9 locus were associated with Cmtm6
(Figure 4D), a gene structurally related to
chemokines, although its exact function is
still unknown. The second component was
strongly associatedwith a locusonchromo-
some 7 spanning approximately 10 Mb that
also coincided with the Hemoglobin beta
locus (Figure 4B). Consistent with the corre-
lationbetween the secondprincipal compo-
nent and fat-related traits, we found that
CpGs at this locus were associated with
several genes including Lipe (Figure 4E), a
lipase gene involved in free fatty acid oxida-
tion (Reid et al., 2008). In addition, we iden-
tified CpGs in chromosome 8 associated
with the second principal component and
with expression levels of Mtor (Figure 4F).
Mtor plays a role in metabolic regulation,
response to nutrients, insulin, and diabetes
(Zhu et al., 2013).
DNA Methylation Can Be Used to
Infer Phenotypes
Genetics and genomics data is a highly
valuable resource that can be used tomodel disease susceptibility and risk. An individual’s genome is
predominantly static, but the epigenome is variable in different
tissues and is affected by transcription patterns. To determine if
CpGs could be used to infer clinical traits in other individuals
based on their methylation status, we built linear models with
CpG sites using the generalized linear model package glmnet
(Friedman et al., 2010), and tested their power to infer clinical
traits in test individuals where the CpG status was known. For
each trait, we randomly selected a test set of ten mice that were
kept hidden from the training set and used the remaining mice
as the training set, where the methylation status was known in
both sets. We used glmnet to select CpGs from the 20,000
most variable CpGs and built a linear model for the trait based
on these CpGs using the training set. We then used the resulting
linear model to infer trait values on the test set of ten mice and
determined the accuracy of the model using Pearson’s correla-
tion between the observed and inferred trait values. We found
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Figure 5. Phenotype Inference
(A and B) Phenotype predictions for (A) bone mineral density and (B) mean cell
volume of red blood cells. The predicted phenotype value is on the x axis and
the measured phenotype value is on the y axis. Each point is a mouse sample.
See also Table S4.several clinical traits that could be accurately inferred on test in-
dividuals from a set of CpG methylation sites, where the trait
values predicted by the model were highly correlated with the
clinical trait values measured in the mice. We found eight clinical
traits with r2 > 0.5, including plasma total cholesterol levels,
plasma HDL cholesterol levels, total bone mineral density,
plasma fatty acids, and red blood cell phenotypes. Examples of
inferred and measured clinical trait values are shown for bone
mineral density (Figure 5A) and for mean cell volume of red blood
cells (Figure 5B). A list of inferredphenotypes, the correlationsbe-
tweenpredictedandobservedphenotypes, and the top tenCpGs
selected to model each phenotype can be found in Table S4.
Natural Genetic Variation InfluencesGenome-Wide DNA
Methylation Levels
To determine the extent to which genetics affects natural varia-
tion in DNA methylation, we used a linear mixed model toCperform GWAS of CpG methylation levels as traits to SNPs
across the mouse genome. We and others have shown that
this method reduces false-positive associations that are due to
population structure (Bennett et al., 2010; Kang et al., 2008).
For each CpG, we associated methylation levels to SNPs with
MAF greater than 10%. We called significant associations at
the Bonferroni threshold (p < 1.4 3 1012) by considering each
CpG and SNP pair as an independent test (Table S5). We chose
this stringent threshold to call significant associations in order to
minimize the possibility of examining false-positive associations.
However, all association results at p < 13 106 can be obtained
from our website at http://ewas.mcdb.ucla.edu/download.html.
We identified 3,017,453 associations betweenmethylation levels
and genetics at the Bonferroni threshold (Figure 6A), corre-
sponding to 26,563 unique CpGs, or 7% of all methylation sites
tested, and 92,959 unique SNPs. Approximately 51% of all sig-
nificant associations were for Hypervariable CpGs, and 52% of
all Hypervariable CpGs (11,644) were under genetic regulation.
We found that 12% of the associations involved SNPs that abol-
ished a CpG in a fraction of the mouse strains (CG-SNPs), corre-
sponding to 2,533 of the CG-SNPs present in the strains. We
note that these CG-SNPs were not used in our EWAS, since dif-
ferences inmethylation between strains were the result of a cyto-
sine change to a different DNA base.
We estimated the variance explained by genetics, or the nar-
row sense heritability of DNA methylation levels for individual
CpGs using an additive model. When we examined all Variable
CpGs, which display variation in methylation levels in at least
one strain, the variance explained by genetics was on average
27% (Figure S7A). In contrast, on average 60% of the variance
was explained by genetics for Hypervariable CpGs, which
display higher variation in methylation among the strains. The
variance explained by genetics was on average 75% for CG-
SNPs. These CG-SNPs do not show 100% heritability, likely
because methylation levels can still be controlled in trans for
the strains with the C allele. A large proportion of the associa-
tions were local or cis. We previously estimated the GWASmap-
ping resolution to be 2 Mb on average (Bennett et al., 2010).
Here, 54% of the associations were local or cis, where SNP
and CpG pairs were within 2 Mb of each other. However, trans
associations where SNP and CpG pairs were more than 2 Mb
from each other were also found in the same chromosome for
approximately 79% of trans associations, suggesting that
many of these associations may be cis associations caused by
long-range LD in SNPs. The distance between SNPs and Hyper-
variable CpGs was on average 1.4 times smaller than the overall
distribution of SNP to CpG distances, and the distance between
SNPs and CG-SNPs was on average 3.6 times smaller than the
overall distribution. The distribution of the distances between
SNP and CpGs pairs is shown on Figure S7B, and results of
the DNA methylation GWAS are summarized in Table S5.
Mtrr Influences Methylation Levels of CpGs across the
Genome
Methylation levels of hundreds of CpGs across the genome
mapped to a QTL hotspot on chromosome 13, defined as a
2Mbbin at 68–70Mb, near the geneMethionine synthase reduc-
tase, Mtrr, located at 68.7 Mb (Figure 6C). This methylation hot-
spot can also be seen as a vertical band on the GWAS plotell Metabolism 21, 905–917, June 2, 2015 ª2015 Elsevier Inc. 911
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Figure 6. Natural Genetic Variation Influ-
ences Genome-Wide DNA Methylation
(A) GWAS usingVariableCpGmethylation levels as
phenotypes and SNPs as predictors. Genomic
position of SNPs is on the x axis, and the genomic
position of CpGs is on the y axis. Each point is a
significant association at the Bonferroni threshold
p < 1.4 3 1012.
(B) Methylation levels for CpGs mapping to the
chromosome 13 GWAS hotspot. Strains are
on the x axis grouped by their genotype of
rs13481861 at theMtrr locus, and CpGs are on the
y axis. The color is the methylation level between
0% and 100%.
(C) CpG methylation GWAS hotspots. The number
of CpGsmapping in trans to each 2Mbbin is on the
y axis. The genomic position of each bin is on the
x axis. The horizontal dotted line is the Poisson
significance threshold for each hotspot bin.
(D and E) Experimental validation of the hotspot at
the Mtrr locus using RRBS in livers of wild-type
mice (+/+) and mice homozygous for the Mtrr
gene-trapped allele (gt/gt).
(D) Distribution of methylation differences. The
difference in methylation between +/+ versus gt/gt
mice is on the x axis, and the cumulative distribu-
tion function is on the y axis. The curves show the
distribution of all CpGs (black), randomly sampled
CpGs (green dotted), and CpGs predicted to be
affected by the Mtrr genotype (red).
(E) Differentially methylated CpGs betweenMtrr+/+
and gt/gt mice at FDR < 5%.Mice are on the x axis,
and CpGs are on the y axis. The color denotes
methylation levels between 0% and 100%. See
also Figure S7.(Figure 6A). Expression levels of Mtrr were variable among the
mouse strains and were regulated in cis, since we observed
both a cis-eQTL for Mtrr using GWAS (p = 1.82 3 1014) and
an association between Mtrr expression and methylation levels
314 bp from Mtrr using EWAS (p = 4.97 3 1014). Expression
levels of Mtrr were highly correlated with methylation levels of
CpGs mapping to the locus both in cis and in trans, with an
average absolute Pearson’s r = 0.48. The distribution of these
correlations was significantly different (KS test p = 4.98 3
10187) from the correlation between Mtrr expression and all
CpGs, which had average absolute r = 0.09 (Figure S7C). Mtrr
is necessary for the utilization of methyl groups from the folate
cycle, which donates methyl groups to multiple cellular
pathways including DNA methylation (Crider et al., 2012).
MTRRwas recently associatedwithmethylation levels in autoim-
mune thyroid disease in humans (Arakawa et al., 2012), along912 Cell Metabolism 21, 905–917, June 2, 2015 ª2015 Elsevier Inc.with DNMT1, DNMT3A, DNMT3B, and
MTHFR. All these suggested that Mtrr
was an ideal candidate gene for the
methylation hotspot.
Based on our GWAS results, we
observed 471CpGs from the HMDPmap-
ping to the chromosome 13 hotspot (Fig-
ure 6B). These CpGs were physically
located throughout the mouse genome,
and we hypothesized that their methyl-ation levels were influenced by Mtrr. To experimentally validate
Mtrr as a causal gene for the chromosome 13 methylation hot-
spot, we measured DNA methylation levels in the livers of Mtrr
wild-type (+/+) and homozygous gene-trappedmice (gt/gt) using
RRBS. Mice homozygous for the gene-trapped allele display
reduced expression, protein, and activity of Mtrr (Elmore et al.,
2007). Of the 471 CpGs mapping to the hotspot, 154 CpGs
were represented in the RRBS data set of Mtrr mice, and 42 of
the 154 (27%) were differentially methylated between Mtrr
wild-type and gt/gt mice at 5% false discovery rate (FDR).
Methylation levels at these differentially methylated sites are
shown on Figure 6E for wild-type and gt/gt mice, as well as the
average methylation levels of mouse strains with the reference
allele (C) or alternate allele (T) for SNP rs13481861 located in
an exon of Mtrr. The list of 154 CpGs we tested using RRBS,
including the methylation delta; the p value for differential
Figure 7. Bone Mineral Density Association
Graph
Association graph of EWAS andGWAS hits. Edges
are defined by EWAS, purple lines; GWAS, red
lines; Cis-associations, solid lines; and Trans-
associations, dotted lines. Node colors are trait,
yellow; CpG, purple; SNP, red; gene expression,
light blue; and protein levels, green. Genes impli-
cated in bone mineral density and/or bone biology
are shown with V shape, and genes implicated in
fat or lipid metabolism are shown as squares.methylation between Mtrr wild-type and gt/gt mice; and the
average methylation of allele C and allele T HMDP strains can
be found in Table S6. We were not able to observe all
471 CpGs because of the decrease in coverage, since we multi-
plexed six samples in one lane for the validation experiments and
two samples per lane for all the HMDP samples.
The difference in methylation (delta) between wild-type and
gt/gt mice was on average 6.7-fold higher in the 154 predicted
CpGs, relative to all CpGs observed in the Mtrr mice (KS test
p = 1.8 3 1033). To test if the differences between Mtrr wild-
type and gt/gt mice at these CpGs were due to chance, we
randomly sampled sets of CpGs across the genome and calcu-
lated the delta between wild-type and gt/gt mice in 1,000 sam-
plings, but we found no significant differences between
randomly sampled CpGs and all observed CpGs. Random sets
of CpGs had an average delta of 0.99% and an average KS
test p = 0.52 forMtrr +/+ versus gt/gt mice across all 1,000 sam-
plings, with a minimum KS test p = 0.001 and maximum delta of
1.1%. In contrast, the 154 CpGs that we hypothesized were
regulated by Mtrr showed an average delta of 20% between
Mtrr+/+ and gt/gt, with KS test p = 1.8 3 1033. The distribution
of methylation differences in Mtrr wild-type and gt/gt mice is
shown on Figure 6D for the 154 predicted CpGs, a set of
randomly sampled CpGs, and all CpGs observed in the Mtrr
mouse RRBS data set.
Online Databases for the Identification of Candidate
Genes
All of our EWAS and GWAS results are available through an on-
line database to facilitate the identification of candidate genes
for clinical traits using DNA methylation patterns, which can be
accessed at http://ewas.mcdb.ucla.edu. We also created an
different online tool that generates association graphs basedCell Metabolism 21, 905–on our results at http://pathways.mcdb.
ucla.edu/network. A sample association
graph for bone mineral density is shown
in Figure 7. Further details on these online
databases can also be found in the Sup-
plemental Information.
DISCUSSION
In this study we leveraged a powerful
mouse systems genetics platform to ask
what the relationship is between DNA
variation and methylation. What are theloci that control methylation levels? How does methylation relate
to clinical traits that are precursors to heart disease and dia-
betes? Can methylation be incorporated into a network and
causal models of complex disease? Our results demonstrate
that using DNAmethylation for GWAS (i.e., EWAS) complements
traditional GWAS.
We identified thousands of associations betweenDNAmethyl-
ation levels and clinical traits such as bone mineral density,
adiposity, plasma cholesterol, glucose, insulin, triglyceride
levels, and molecular traits such as metabolites, protein, and
gene expression levels (Figure 2). Roughly 15% of EWAS hits
for clinical traits could also be found using GWAS in the same
panel of mouse strains, but the remaining associations were
unique to the EWAS (Figure S5A). The low overlap between
methylation and genetic associations for clinical traits may be
due a lack of statistical power to detect associations with small
effects. Since molecular traits are typically less complex relative
to clinical traits, we were more likely to detect associations for
gene expression and protein levels, and indeed, we observed
a much larger overlap for cis expression (77%) and cis protein
associations (37%) identified with EWAS and GWAS. In cases
where associations are identified by both EWAS and GWAS,
we asked whether methylation was mediating the effect on
the trait. We used a CIT to address this question, and found ev-
idence that DNAmethylation wasmediating the effect on the trait
in 24% of the overlapping clinical trait associations, and 22% of
the overlapping cis expression associations. However, we note
that it is often difficult to establish causal relationships for either
genetic or epigenetic associations for a number of reasons,
including the complexity of biological pathways, LD, and statis-
tical power. In addition, although the CIT examines the model
where a locus affects methylation and methylation affects the
trait (L/M/T), there are other possible scenarios not tested917, June 2, 2015 ª2015 Elsevier Inc. 913
by the CIT, such as where DNAmethylation changes are reactive
and are not mediators of the association.
DNA methylation levels are dynamic and can be modified in
response to disease, age, and environmental perturbations. In
contrast, the genome remains largely static throughout an indi-
vidual’s lifetime and is modified only in certain diseases such
as cancer. We found that correlations in CpG methylation pat-
terns were significantly smaller than correlations in SNP geno-
types (LD), leading to a dramatic increase in our association
mapping resolution (Figures 1 and S3). LD blocks are typically
much larger in laboratory mice than in human populations, due
the breeding history of existing mouse strains. Hence, we would
not expect a similar increase in mapping resolution using EWAS
in human populations. The extensive LD in mice has been a
major difficulty for candidate gene identification in mouse ge-
netics studies, and we found that this can be largely overcome
using EWAS in mice. We hypothesize that the plasticity in the
epigenome allows methylation patterns to be at least partly de-
coupled from local genetic patterns, since CpG methylation
can be modified by chromatin binding proteins in trans. In
contrast, SNP genotypes are static, and LD patterns remain
fixed in the population.
In addition, DNA methylation patterns can vary across
different tissues. One of the advantages of studies inmammalian
model organisms such as the mouse is the ability to sample tis-
sues that are not readily available in human studies. A previous
study identified methylation associations using blood for rheu-
matoid arthritis in humans (Liu et al., 2013), and in the current
study, we found associations for bone mineral density and
methylation levels in the liver (Figures 7 and S6). These findings
suggest that it is possible to uncover significant associations for
methylation patterns that are conserved between the tissue that
is sampled and the tissue relevant to the trait of interest, but as-
sociations to methylation levels that are not conserved are likely
to be missed. We believe that there is potentially a large amount
of information to be gained from studying relevant tissues when-
ever possible.
We examined the degree to which methylation is controlled by
genetics by taking methylation patterns of individual CpGs as
phenotypes and mapping them to the SNP genotypes using
GWAS. We found that 7% of all CpGs and 52% of Hypervariable
CpGs were under genetic control (Figure 6A). A large proportion
(55%) of these associations were in cis, where the CpG and SNP
were found within 2 Mb of each other. Although only 7% of all
CpGs we examined were significantly associated with SNPs, it
is possible that we did not have sufficient power to identify addi-
tional associations, particularly for genetic variants with subtle
effects on DNA methylation. In addition, we note that CpGs
with minimal or no variation in methylation levels would not be
significantly associated even if they were stably maintained
across generations. Previous human methylation studies, or
mQTL studies, found that 20%of variable CpGswere associated
with genetic variation in blood leukocytes (McRae et al., 2014)
and 28% in adipose tissue (Grundberg et al., 2013).We observed
an average heritability of 27% for all CpGs and 60% for Hyper-
variable CpGs in the liver of mouse inbred strains, excluding
CG-SNPs. In comparison, heritability in previous human twin
studies was on average 12% in cord blood mononuclear cells,
7% in human umbilical vein endothelial cells (Gordon et al.,914 Cell Metabolism 21, 905–917, June 2, 2015 ª2015 Elsevier Inc.2012), 19% in blood leukocytes (McRae et al., 2014), andmedian
heritability of 34% in adipose tissue in the MuTHER cohort
(Grundberg et al., 2013). These results support the notion that
DNA methylation levels are indeed associated with genetic vari-
ation, although the extent of the heritability and genetic effects is
variable across different tissues and population samples.
Although the majority of associations between CpG methyl-
ation levels and genetics were in cis, we found a trans associa-
tion hotspot where methylation levels of CpGs across the
genome map to a locus in chromosome 13 near Mtrr (Figures
6A and 6C), a gene necessary for the utilization of methyl groups
from the folate cycle. This suggested that natural genetic varia-
tion in a population can influence genome-wide DNAmethylation
levels. The FAST kinase gene Fast3kd was also located on chro-
mosome 13 nearMtrr, and is another candidate gene for the hot-
spot. Unfortunately, Fastkd3 was not represented in either our
gene expression or protein data sets, and we could not observe
any cis-eQTL or cis expression EWAS hits for this gene. Although
Fastkd3 may also be a candidate for the hotspot, it contains a
mitochondrial-targeting domain and functions primarily in the
mitochondria, making it a less likely candidate thanMtrr for influ-
encing CpG methylation levels in trans. We confirmed the role of
Mtrr in 27% CpGs predicted to be affected by the chromosome
13 hotspot, since these CpGs were differentially methylated be-
tween wild-type and gt/gt mice (Figure 6E). The validation results
of the chromosome 13 hotspot we present here are consistent
with our previous work on a gene expression hotspot on mouse
chromosome 8 in primary macrophages (Orozco et al., 2012),
where we experimentally validated 12% of the genes predicted
to map to the chromosome 8 hotspot.
One of the most desirable applications since the advent of the
human genome project has been to be able to determine a per-
son’s phenotype from their genome sequence. However, under-
standing how genetic variation alters cellular behavior and
organismal phenotypes, and accurately inferring phenotypes
from raw genotypes has proved to be an extremely difficult
endeavor. A recent study demonstrated that modeling of SNPs
fromwhole-genome sequencing data could be used to infer star-
vation resistance and startle response in Drosophila (Ober et al.,
2012). Here we show that DNA methylation patterns can be
used to infer complex phenotypes in a mammalian organism,
including bone mineral density, blood cell phenotypes, and
plasma cholesterol levels (Figure 5; Table S4). We built linear
models that incorporate the DNA methylation status at specific
CpGs and used these models to infer clinical traits in other indi-
viduals in the same cohort whosemethylation status was known.
We note that the statistical inference approach we used to
model, or explain, a phenotype is distinct from longitudinal pre-
diction of phenotypes for a given individual at a future time.
Association studies over the past 10 years have found that the
majority of genetic polymorphisms associated with traits are
outside protein-coding regions. The associated genetic poly-
morphisms are thought not to alter genes themselves, but rather
regulatory elements that control gene expression (Furey and Se-
thupathy, 2013). Our findings suggest that DNA variants can act
by regulating DNAmethylation, which in turn affects regulation of
gene expression or protein levels of genes that function in biolog-
ical mechanisms important for the phenotype expression. We
hypothesize that it is the plasticity in DNAmethylation thatmakes
it ideal for quantitative trait modeling. Since DNA methylation
patterns are specific to developmental stages and cell types
and can vary in response to the environment or disease, they
can capture the cellular status and provide a more detailed
picture of dynamic cellular behavior than our static genomes.
Ultimately, our studies suggest that CpG methylation patterns
are themselves under genetic control, but because they are
more responsive to an organism’s state, they can provide added
information that cannot be obtained from the genetic sequence
alone.
EXPERIMENTAL PROCEDURES
A more detailed version of the experimental procedures can be found in the
Supplemental Information.
Mice
All animals were handled in strict accordance with good animal practice as
defined by the relevant national and local animal welfare bodies, and all animal
experiments and work were carried out with UCLA IACUC approval.
Data Access
All RRBS sequencing and SNP data can be obtained from GEO: GSE67507.
The EWAS and GWAS results can be accessed in our online databases to
search for candidate genes at http://ewas.mcdb.ucla.edu and to generate
association graphs at http://pathways.mcdb.ucla.edu/network. Individual
tables with all methylation associations can be downloaded from http://
ewas.mcdb.ucla.edu/download.html. The GWAS results can also be ac-
cessed at http://systems.genetics.ucla.edu/data/hmdp.
RRBS Libraries
We prepared RRBS libraries as previously described (Smith et al., 2009), with
minor modifications. We sequenced the libraries by multiplexing two libraries
per lane in an Illumina HiSeq sequencer, with 100 bp reads.
Alignment
We aligned the reads with BS-Seeker2 (Guo et al., 2013) to the mm9
mouse reference genome. We used Bowtie as the base aligner, trimmed
adapters, allowed for up to five mismatches, and selected uniquely aligned
reads.
LD and CpG Correlation Studies
We computed the Pearson’s r2 between pairs of SNPs, or pairs of CpGs,
excluding missing values.
EWAS
We used the linear mixed model package pyLMM (https://github.com/
nickFurlotte/pylmm) to test for association and to account for population
structure and relatedness among the mouse strains. This method was previ-
ously described as EMMA (Kang et al., 2008), and we implemented the
model in Python to allow for continuous predictors, such as CpG methylation
levels that vary between 0 and 1. We applied the model y=m+ xb+ u+ e,
where m = mean, x = CpG, b = CpG effect, and u = random effects due to
relatedness, with Var(u) = sg
2K and Var(e) = se
2, where K = IBS (identity-
by-state) matrix across all Variable CpGs. We computed a restricted
maximum likelihood estimate for sg
2K and se
2, and we performed associa-
tion based on the estimated variance component with an F test to test
that b does not equal 0. Each phenotype was log transformed for the asso-
ciation test.
Inflation
We calculated the inflation factor lambda by taking the chi-square inverse
cumulative distribution function for the median of the association p values,
with one degree of freedom, and divided this by the chi-square probability
distribution function of 0.5 (the median expected p value by chance) with
one degree of freedom.COverlap of EWAS and GWAS
We defined an overlap between EWAS and GWAS if the associations were
found within 2Mb (Figure S5A). To decrease the chance of not finding an over-
lap based on our stringent Bonferroni EWAS thresholds, we used the per
phenotype Bonferroni threshold of p < 1 3 107 for EWAS and p < 4.1 3
106 for the GWAS as previously described (Bennett et al., 2010).
Conditional EWAS
We performed EWAS for clinical traits or cis expression associations identified
with both EWAS and GWAS. We used the pyLMM package as described with
onemodification: for each EWAS, we used the SNP genotype for the GWAS hit
as a covariate.
CIT
We performed CITs using the R statistical package CIT developed by Millstein
and colleagues (Millstein et al., 2009), according to the user’s manual.
PCA
We performed a principal-component analysis on the clinical traits. The first
and second principal components explained 24% and 12% of the variation
in the traits, respectively. We mapped the first two principal components as
traits to CpG methylation levels across the genome using EWAS as described
above.
Methylation GWAS
We tested for association between methylation levels as phenotypes, and
SNPs as predictors using EMMA as previously described (Bennett et al.,
2010). The difference between the EWAS model described above, and the
GWAS linear mixed model is that in GWAS x = SNP, b = SNP effect, and K =
IBS (identity-by-state) matrix across all SNPs.
Methylation GWAS Hotspots
We divided the genome into 2 Mb bins and counted the number of all unique
CpGs with a significant GWAS hit in that bin and called these ‘‘cis and trans’’
associations (Figure S7E). We also defined a set of trans association hotspots
(Figure 6C), where we counted CpGs mapping to each bin in trans, such that
the CpG was physically located at least 10 Mb away from the bin. We consid-
ered CpGs to be associated at the Bonferroni threshold with p < 1.4 3 1012.
We used the Poisson distribution to determine if individual bins had a higher
than expected number of associations.
Validation of Mtrr Hotspot
We generated RRBS libraries from Mtrr gene-trapped mice (Elmore et al.,
2007), using three wild-type and three homozygous gene trapped (gt/gt)
male mice at 3 months of age. We sequenced the libraries by multiplexing
all six libraries in one lane and aligned the data using BS-Seeker2 as described
above. We compared CpG methylation levels in +/+ and gt/gt mice using a
t test and estimated the FDR using the Storey method (Storey, 2002). We
calculated the difference in methylation levels at each CpG by taking the ab-
solute difference in methylation between the average methylation Mtrr+/+
and the average in / mice (i.e., delta methylation).
Phenotype Inference
We used the glmnet package in R for building linear models, which fits a gener-
alized linear model via penalized maximum likelihood (Friedman et al., 2010).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, six tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2015.04.025.
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